Table 4.

Studies on impact of ⁶⁸Ga-DOTA-peptide PET/CT in the management of NET

Studies	Number of patients	Percentage change of intended management, %
Ambrosini et al. [11] Hofman et al. [10] Hermann et al. [12] Naswa et al. [9] Skoura et al. [13]	90 59 88 109 728	36.2% Intermodality change 47% 60% 19% 40.9%